Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB2 [1] ADRB2 💬Adrenergic signaling in cardiomyocytes
|
Formoterol fumarate Formoterol fumarate 💬Adrenergic signaling in cardiomyocytes
| Formoterol | 085 [4] 85, 228, 299, 306 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB2 [1] ADRB2 💬Adrenergic signaling in cardiomyocytes
|
Formoterol Formoterol 💬Adrenergic signaling in cardiomyocytes
| Formoterol | 085 [4] 85, 228, 299, 306 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||
| 3 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB2 [1] ADRB2 💬Calcium signaling pathway
|
Formoterol fumarate Formoterol fumarate 💬Calcium signaling pathway
| Formoterol | 085 [4] 85, 228, 299, 306 💬3. Calcium signaling pathway
|
||||||||||||||||||||||||||
| 4 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB2 [1] ADRB2 💬Calcium signaling pathway
|
Formoterol Formoterol 💬Calcium signaling pathway
| Formoterol | 085 [4] 85, 228, 299, 306 💬3. Calcium signaling pathway
|
||||||||||||||||||||||||||
| 5 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB2 [1] ADRB2 💬cAMP signaling pathway
|
Formoterol fumarate Formoterol fumarate 💬cAMP signaling pathway
| Formoterol | 085 [4] 85, 228, 299, 306 💬5. cAMP signaling pathway
|
||||||||||||||||||||||||||
| 6 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB2 [1] ADRB2 💬cAMP signaling pathway
|
Formoterol Formoterol 💬cAMP signaling pathway
| Formoterol | 085 [4] 85, 228, 299, 306 💬5. cAMP signaling pathway
|
||||||||||||||||||||||||||
| 7 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB2 [1] ADRB2 💬cGMP-PKG signaling pathway
|
Formoterol fumarate Formoterol fumarate 💬cGMP-PKG signaling pathway
| Formoterol | 085 [4] 85, 228, 299, 306 💬7. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||
| 8 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB2 [1] ADRB2 💬cGMP-PKG signaling pathway
|
Formoterol Formoterol 💬cGMP-PKG signaling pathway
| Formoterol | 085 [4] 85, 228, 299, 306 💬7. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||
| 9 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB2 [1] ADRB2 💬Chemical carcinogenesis - receptor activation
|
Formoterol fumarate Formoterol fumarate 💬Chemical carcinogenesis - receptor activation
| Formoterol | 085 [4] 85, 228, 299, 306 💬9. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||
| 10 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB2 [1] ADRB2 💬Chemical carcinogenesis - receptor activation
|
Formoterol Formoterol 💬Chemical carcinogenesis - receptor activation
| Formoterol | 085 [4] 85, 228, 299, 306 💬9. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||
| 11 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL4R [1] IL4R 💬Cytokine-cytokine receptor interaction
|
Dupilumab Dupilumab 💬Cytokine-cytokine receptor interaction
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬11. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||
| 12 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
IL4R [1] IL4R 💬Hematopoietic cell lineage
|
Dupilumab Dupilumab 💬Hematopoietic cell lineage
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬12. Hematopoietic cell lineage
|
||||||||||||||||||||||||||
| 13 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB2 [1] ADRB2 💬Hormone signaling
|
Formoterol fumarate Formoterol fumarate 💬Hormone signaling
| Formoterol | 085 [4] 85, 228, 299, 306 💬13. Hormone signaling
|
||||||||||||||||||||||||||
| 14 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB2 [1] ADRB2 💬Hormone signaling
|
Formoterol Formoterol 💬Hormone signaling
| Formoterol | 085 [4] 85, 228, 299, 306 💬13. Hormone signaling
|
||||||||||||||||||||||||||
| 15 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL4R [1] IL4R 💬Inflammatory bowel disease
|
Dupilumab Dupilumab 💬Inflammatory bowel disease
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬15. Inflammatory bowel disease
|
||||||||||||||||||||||||||
| 16 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
IL4R [1] IL4R 💬JAK-STAT signaling pathway
|
Dupilumab Dupilumab 💬JAK-STAT signaling pathway
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬16. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||
| 17 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB2 [1] ADRB2 💬Neuroactive ligand signaling
|
Formoterol fumarate Formoterol fumarate 💬Neuroactive ligand signaling
| Formoterol | 085 [4] 85, 228, 299, 306 💬17. Neuroactive ligand signaling
|
||||||||||||||||||||||||||
| 18 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB2 [1] ADRB2 💬Neuroactive ligand signaling
|
Formoterol Formoterol 💬Neuroactive ligand signaling
| Formoterol | 085 [4] 85, 228, 299, 306 💬17. Neuroactive ligand signaling
|
||||||||||||||||||||||||||
| 19 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB2 [1] ADRB2 💬Neuroactive ligand-receptor interaction
|
Formoterol fumarate Formoterol fumarate 💬Neuroactive ligand-receptor interaction
| Formoterol | 085 [4] 85, 228, 299, 306 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 20 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB2 [1] ADRB2 💬Neuroactive ligand-receptor interaction
|
Formoterol Formoterol 💬Neuroactive ligand-receptor interaction
| Formoterol | 085 [4] 85, 228, 299, 306 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 21 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Fluticasone Fluticasone 💬Neuroactive ligand-receptor interaction
| Fluticasone | 098 [4] 98, 228, 299, 306 💬21. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 22 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Fluticasone propionate Fluticasone propionate 💬Neuroactive ligand-receptor interaction
| Fluticasone propionate | 098 [3] 98, 228, 306 💬22. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||
| 23 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
IL4R [1] IL4R 💬Pathways in cancer
|
Dupilumab Dupilumab 💬Pathways in cancer
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬23. Pathways in cancer
|
||||||||||||||||||||||||||
| 24 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
IL4R [1] IL4R 💬PI3K-Akt signaling pathway
|
Dupilumab Dupilumab 💬PI3K-Akt signaling pathway
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬24. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||
| 25 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB2 [1] ADRB2 💬Regulation of lipolysis in adipocytes
|
Formoterol fumarate Formoterol fumarate 💬Regulation of lipolysis in adipocytes
| Formoterol | 085 [4] 85, 228, 299, 306 💬25. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||
| 26 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB2 [1] ADRB2 💬Regulation of lipolysis in adipocytes
|
Formoterol Formoterol 💬Regulation of lipolysis in adipocytes
| Formoterol | 085 [4] 85, 228, 299, 306 💬25. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||
| 27 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB2 [1] ADRB2 💬Renin secretion
|
Formoterol fumarate Formoterol fumarate 💬Renin secretion
| Formoterol | 085 [4] 85, 228, 299, 306 💬27. Renin secretion
|
||||||||||||||||||||||||||
| 28 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB2 [1] ADRB2 💬Renin secretion
|
Formoterol Formoterol 💬Renin secretion
| Formoterol | 085 [4] 85, 228, 299, 306 💬27. Renin secretion
|
||||||||||||||||||||||||||
| 29 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB2 [1] ADRB2 💬Salivary secretion
|
Formoterol fumarate Formoterol fumarate 💬Salivary secretion
| Formoterol | 085 [4] 85, 228, 299, 306 💬29. Salivary secretion
|
||||||||||||||||||||||||||
| 30 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB2 [1] ADRB2 💬Salivary secretion
|
Formoterol Formoterol 💬Salivary secretion
| Formoterol | 085 [4] 85, 228, 299, 306 💬29. Salivary secretion
|
||||||||||||||||||||||||||
| 31 | Th1 and Th2 cell differentiation 💬 45 genes, 57 drugs (DrugBank) and 83 diseases |
IL4R [1] IL4R 💬Th1 and Th2 cell differentiation
|
Dupilumab Dupilumab 💬Th1 and Th2 cell differentiation
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬31. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||
| 32 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL4R [1] IL4R 💬Th17 cell differentiation
|
Dupilumab Dupilumab 💬Th17 cell differentiation
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬32. Th17 cell differentiation
|
Adrenergic signaling in cardiomyocytes
31 genes, 86 drugs (DrugBank) and 81 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Cytokine-cytokine receptor interaction
90 genes, 141 drugs (DrugBank) and 104 diseases
Hematopoietic cell lineage
47 genes, 97 drugs (DrugBank) and 101 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Inflammatory bowel disease
38 genes, 49 drugs (DrugBank) and 75 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Salivary secretion
20 genes, 75 drugs (DrugBank) and 75 diseases
Th1 and Th2 cell differentiation
45 genes, 57 drugs (DrugBank) and 83 diseases
Th17 cell differentiation
57 genes, 88 drugs (DrugBank) and 111 diseases
